Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer

2530.0000 -51.40 (-1.99%)

NSE Jun 19, 2025 15:29 PM

27.40% Fall from 52W High

Volume: 45,126

Ajanta Pharma Ltd.

11 Dec 2024

2530.00

-1.99%

Ajanta Pharma (SELL): No incremental triggers; valuation expensive

Sell: Ajanta Pharma Ltd.

Recommendation Target

BOB Capital Markets Ltd.

At our virtual conference AJP said it is not looking to venture into newer therapies in India in the next 1-2 years due to hefty valuations

Promoters pledged 1.44% of shares in last quarter. Total pledge stands at 12.61% of promoter holdings